Verition Fund Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-96,973
Closed -$274K – 2308
2025
Q4
$274K Buy
96,973
+31,011
+47% +$160K ﹤0.01% 3048
2025
Q3
$459K Sell
65,962
-29,169
-31% -$206K ﹤0.01% 3076
2025
Q2
$563K Buy
95,131
+69,427
+270% +$399K ﹤0.01% 2865
2025
Q1
$164K Sell
25,704
-21,626
-46% -$208K ﹤0.01% 3093
2024
Q4
$562K Buy
47,330
+21,377
+82% +$364K ﹤0.01% 2412
2024
Q3
$719K Buy
25,953
+5,586
+27% +$140K ﹤0.01% 2098
2024
Q2
$486K Buy
+20,367
New +$478K ﹤0.01% 2068

Other funds holding ASPN

Verition Fund Management's ASPN Position: Q1 2026 in Review

Verition Fund Management sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 96,973 shares — an estimated $274K sold.

Verition Fund Management first reported a position in ASPN in Q2 2024 and held it in 7 quarters. The position peaked at $719K in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Verition Fund Management reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 96,973 Aspen Aerogels shares in Q1 2026, an estimated $274K.
  • Verition Fund Management first reported a position in Aspen Aerogels in Q2 2024 and held it in 7 quarters.
  • Verition Fund Management's Aspen Aerogels position peaked at $719K in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.